Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

OSI receives patent protection for its gene transcription-regulating drugs

July 20, 1998

Trega identifies lead compounds in R&D collaboration with Ono

July 17, 1998

Bioject enters vaccine delivery agreement with Merck

July 17, 1998

Nexell's Isolex technology receives U.S. patent protection; FDA requests more data

July 16, 1998

Cyclacel licenses novel drug delivery technology from CNRS

July 15, 1998

MacroChem and American Home Products sign collaborative agreement

July 13, 1998

Iomed and Novartis to discontinue research collaboration

July 9, 1998

Sheffield and Elan finalize pulmonary drug delivery collaboration

July 9, 1998

Oxford Molecular Group enters research collaboration with Mitsubishi Chemical

July 6, 1998

Abgenix and Genentech expand collaboration

July 2, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...